Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115657) titled 'Effect of sacubitril/valsartan and ACEI/ARB on left ventricular remodeling in patients with STEMI after PCI: a prospective, superiority randomized controlled trial' on Dec. 29, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: General Hospital of the Northern Theater Command, People's Liberation Army, No.83 Wenhua Road, Shenhe District, Shenyang City, Liaoning Province
Condition:
STEMI
Intervention:
Test group (randomized): Sacubitril/Valsartan:The experimental group was administered sacubitril valsartan.
Control group (randomized): ACEI/ARB:The control group received benazepri...